Chimeric Antigen Receptor T-Cell Therapy: The Light of Day for OsteosarcomaChimeric Antigen Receptor T-Cell Therapy: The Light of Day for Osteosarcoma
|
| 0 Comment
Osteosarcoma (OS) is the most typical malignant bone tumor, arising primarily in youngsters and adolescents. With the introduction of multiagent chemotherapy, the therapies of OS have remarkably improved, however the